Hospital Universitario de Guadalajara-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2024

  1. Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice

    Medicina (Lithuania), Vol. 60, Núm. 1

2023

  1. Updated Views in Targeted Therapy in the Patient with Non-Small Cell Lung Cancer

    Journal of Personalized Medicine, Vol. 13, Núm. 2

2022

  1. Clinical Applications of Classical and Novel Biological Markers of Pancreatic Cancer

    Cancers, Vol. 14, Núm. 8

  2. Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies

    Current Oncology, Vol. 29, Núm. 4, pp. 2442-2453

  3. Prognostic role of IRS-4 in the survival of patients with pancreatic cancer

    Histology and histopathology, Vol. 37, Núm. 5, pp. 449-459

  4. Understanding the basis of major depressive disorder in oncological patients: Biological links, clinical management, challenges, and lifestyle medicine

    Frontiers in Oncology, Vol. 12

2013

  1. Circulating sICAM-1 and sE-Selectin as biomarker of infection and prognosis in patients with systemic inflammatory response syndrome

    European Journal of Internal Medicine, Vol. 24, Núm. 2, pp. 132-138

  2. Early alterations of B cells in patients with septic shock

    Critical Care, Vol. 17, Núm. 3

2010

  1. Human brucellosis is characterized by an intense Th1 profile associated with a defective monocyte function

    Infection and Immunity, Vol. 78, Núm. 7, pp. 3272-3279